{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:38:20Z","timestamp":1768016300695,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007478","name":"Japan Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jjcc.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T08:53:59Z","timestamp":1549011239000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction \u2013 A report from the JASPER registry"],"prefix":"10.1016","volume":"73","author":[{"given":"Yu","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiomi","family":"Yoshihisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1619-268X","authenticated-orcid":false,"given":"Tsutomu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-6617","authenticated-orcid":false,"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2019.01.005_bib0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0290","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2012.10.029","article-title":"Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)","volume":"165","author":"Mentz","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0305","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"Henkel","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0315","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0325","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","article-title":"Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction \u2013 a report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry","volume":"82","author":"Nagai","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0330","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine \u2013 reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0335","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11739-015-1319-0","article-title":"Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease","volume":"11","author":"Marcun","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0340","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurjhf\/hfq157","article-title":"Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease","volume":"12","author":"Kwon","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2017.09.004","article-title":"Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure","volume":"250","author":"Wakabayashi","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","article-title":"Chronic obstructive pulmonary disease and cardiovascular disease","volume":"162","author":"Bhatt","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0355","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"et al., 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jacc.2017.05.043","article-title":"Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: part 3 of a 3-part series","volume":"70","author":"Niemann","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0365","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jjcc.2017.03.001","article-title":"Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease","volume":"70","author":"Onishi","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jjcc.2017.03.010","article-title":"Impact of red blood cell distribution width on non-cardiac mortality in patients with acute decompensated heart failure with preserved ejection fraction","volume":"70","author":"Imai","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0380","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0385","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1378\/chest.14-0607","article-title":"Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study","volume":"147","author":"Fisher","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0390","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/ejhf.946","article-title":"What can we learn from pulmonary function testing in heart failure?","volume":"19","author":"Magnussen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0395","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/ajrccm.162.2.9908056","article-title":"Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study","volume":"162","author":"Boussuges","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0400","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.13-0183","article-title":"Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study","volume":"144","author":"Smith","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/eci.12181","article-title":"Coronary artery disease concomitant with chronic obstructive pulmonary disease","volume":"44","author":"Roversi","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0415","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0420","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jjcc.2014.02.003","article-title":"Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease","volume":"64","author":"Yoshihisa","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0425","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0435","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2010.03.019","article-title":"Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data","volume":"159","author":"Sato","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0440","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ejhf.280","article-title":"Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial","volume":"17","author":"Greene","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0445","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0450","first-page":"597","article-title":"Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012\u20132013","volume":"9","author":"Landis","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1139\/y01-031","article-title":"Mechanical load-induced alterations in B-type natriuretic peptide gene expression","volume":"79","author":"Tokola","year":"2001","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0460","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure","volume":"47","author":"Iwanaga","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0465","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1253\/circj.CJ-16-1282","article-title":"B-type natriuretic peptide in heart failure with preserved ejection fraction- relevance to age-related left ventricular modeling in Japanese","volume":"81","author":"Harada","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0470","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","article-title":"Uric acid and the kidney","volume":"29","author":"Fathallah-Shaykh","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0475","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1183\/09031936.00209212","article-title":"Serum uric acid as a predictor of mortality and future exacerbations of COPD","volume":"43","author":"Bartziokas","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0480","first-page":"831","article-title":"Diagnosis, treatment, and prevention of gout","volume":"90","author":"Hainer","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0485","first-page":"BC09","article-title":"Serum uric acid in chronic obstructive pulmonary disease: a hospital based case control study","volume":"11","author":"Sarangi","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0490","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2017.06.057","article-title":"Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction","volume":"120","author":"Palazzuoli","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0495","first-page":"2519","article-title":"Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease","volume":"10","author":"Zhang","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0500","doi-asserted-by":"crossref","first-page":"H1123","DOI":"10.1152\/ajpheart.00533.2015","article-title":"Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction","volume":"309","author":"Shimizu","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0505","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1751-7133.2011.00216.x","article-title":"Cardiopulmonary exercise testing is a core assessment for patients with heart failure","volume":"17","author":"Arena","year":"2011","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0510","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.CIR.103.7.967","article-title":"Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis","volume":"103","author":"Ponikowski","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0515","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0520","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","article-title":"Chronic obstructive pulmonary disease and cardiac diseases. an urgent need for integrated care","volume":"194","author":"Roversi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0525","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-2600(16)00097-7","article-title":"Management of chronic obstructive pulmonary disease beyond the lungs","volume":"4","author":"Vanfleteren","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0530","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0535","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0540","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0545","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0550","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0555","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2019.01.005_bib0560","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2014.15241","article-title":"Association between use of beta-blockers and outcomes in patients with heart failure and preserved ejection fraction","volume":"312","author":"Lund","year":"2014","journal-title":"JAMA"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719300103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719300103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:00:39Z","timestamp":1760274039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508719300103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0914508719300103"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.01.005","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction \u2013 A report from the JASPER registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}